跳至主要内容
临床试验/NCT07021131
NCT07021131尚未招募不适用

Continuous Serratus Posterior Plane Block Versus Continuous Erector Spine Plane Block for Video-assisted Thoracoscopic Surgery: a Prospective Randomized Non-inferiority Trial

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Cumulative opioid dose in 72 hours

研究概览

简要总结

Analgesia related to the administration of local anesthetic solution into the fascia of erector spinae muscle is mediated by the effect of local anesthetic on the posterior and lateral branches of the anterior part of the spinal nerve. Comparable analgesic efficiency after the administration of both nerve blocks would reject the widespread theory of the paravertebral site of effect of the local anesthetic in ESPB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patiens undergoing VATS-surgery

排除标准

  • Age < 20 years
  • Body Mass Index >35 kg/m2
  • Technical difficulties with the nerve block administration and/or subsequent bolus application
  • Abnormal course of the surgery (e.g. conversion to thoracotomy) or the postoperative phase (e.g. surgical revision of the chest)
  • Patient's refusal

结局指标

主要结局

Cumulative opioid dose in 72 hours

时间窗: from end of surgery to 72 hours after the end surgery

Irrespective of the type of the block, 20 mls of 0.25 % bupivacaine will be administered to the block catether every 8 hours. Every patients will receive non-opioid analgesics according to standardized ward guideline. VAS score is recorded at least every 3 hours (except for time patient is asleep). Any time patient reports VAS score \>=5, he/she will receive 5 mg of morphine intravenously (or equivalent dose of Oxycodone per os). Cumulative dose of opioids will be recorded.

次要结局

未报告次要终点

研究者

发起方
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Nalos

senior researcher

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

研究点 (1)

Loading locations...

相似试验